(trenbolone acetate and estradiol)
For feedlot steers and heifers.
As part of an aggressive implant strategy, REVALOR-200 increases rate of gain and improves feed efficiency in feedlot cattle.
This product contains trenbolone acetate and estradiol in a slow-release delivery system which increases rate of weight gain and improves feed efficiency in steers and heifers fed in confinement for slaughter.
Do not use in veal calves. Effectiveness and animal safety in veal calves have not been established.
Revalor®-200 is not better for increased average daily gain or improved feed efficiency than Revalor®-H (140 mg trenbolone acetate/14 mg estradiol) in heifers fed in confinement for slaughter.
Studies have demonstrated that the administration of Revalor®-200 can result in decreased marbling scores when compared to non-implanted steers and heifers.
One implant containing 200 mg trenbolone acetate and 20 mg estradiol is administered to each animal. The 10 pellets which make up the dosage of Revalor®-200 are contained in one division of the multiple dose cartridge. Ten doses are in each cartridge. The cartridge is designed to be used with a special implant gun.
Box of 10 x 10 cartridge implants.
Store unopened product at or below 25°C (77°F). Avoid excessive heat and humidity. Use product before the expiration date printed on the label and on the cartridge pouch. Opened cartridges may be stored in the foil pouch protected from light in the refrigerator (2-8°C/36-47°F) for up to 6 months.
Not to be used in animals intended for subsequent breeding, or in dairy animals. For Animal Treatment Only. Not for Use in Humans. Implant pellets in the ear only. Any other location is in violation of Federal Law. Do not attempt salvage of implanted site for human or animal food.
A withdrawal period has not been established for this product in pre-ruminating calves. Do not use in calves to be processed for veal.
Take a look at the other implant options available from Merck Animal Health.
Sign up! Receive cattle health management insights, industry news and more straight to your inbox.